[Isosorbide dinitrate ointment in the long-term treatment of intermittent claudication]. 1984

R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate

We evaluated the long-term therapy with Isosorbide Dinitrate Ointment (ISDN-O): 300 mg daily on the painful leg area in 20 male patients (pts) affected by Intermittent Claudication. The efficacy of the treatment was assessed on the basis of the subjective evaluation of pain threshold (daily diary) and objectively by repeated treadmill stress tests performed by each patient at a constant speed, selected according to the severity of symptoms, and by the evaluation of changes both of the distance walked without symptoms (DWS) and of the maximal distance reached (MDR). The maximal duration of the test was 15 minutes independently from the speed. The reproducibility of treadmill tests and the acute effect of isosorbide dinitrate ointment administration were preliminarly evaluated in 2 groups of 5 patients each. The distance walked without symptoms and maximal distance reached in two control stress tests performed in two successive days were: distance walked without symptoms 37 +/- 29 vs 36 +/- 22 m (NS) and maximal distance reached 97 +/- 40 vs 98 +/- 37 m (NS). During the control period and 1 hour after the drug administration distance walked without symptoms was 34 +/- 31 vs 43 +/- 50 m (NS) and maximal distance reached 89 +/- 53 vs 97 +/- 57, (NS) respectively. In a group of 5 patients the effect of one month administration of placebo was evaluated: distance walked without symptoms was m 68 +/- 29 and m 104 +/- 62 and maximal distance reached was m 156 +/- 103 and m 188 +/- 97 basally and after 1 month of placebo (NS).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007383 Intermittent Claudication A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE. Claudication, Intermittent
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005081 Exercise Therapy A regimen or plan of physical activities designed and prescribed for specific therapeutic goals. Its purpose is to restore normal musculoskeletal function or to reduce pain caused by diseases or injuries. Rehabilitation Exercise,Remedial Exercise,Therapy, Exercise,Exercise Therapies,Exercise, Rehabilitation,Exercise, Remedial,Exercises, Rehabilitation,Exercises, Remedial,Rehabilitation Exercises,Remedial Exercises,Therapies, Exercise
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
January 1983, Zeitschrift fur Kardiologie,
R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
January 1984, VASA. Zeitschrift fur Gefasskrankheiten,
R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
January 2003, Digestive surgery,
R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
July 1978, International journal of clinical pharmacology and biopharmacy,
R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
December 1957, Angiology,
R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
January 1976, Giornale italiano di cardiologia,
R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
June 1982, Wiener medizinische Wochenschrift (1946),
R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
April 1980, La Clinica terapeutica,
R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
August 2000, International journal of colorectal disease,
R Testa, and A Biagini, and C Carpeggiani, and M G Mazzei, and C Michelassi, and M Emdin, and A L'Abbate
February 2001, Angiology,
Copied contents to your clipboard!